|
Volumn 12, Issue 7, 2001, Pages 595-602
|
Sequence-dependent cytotoxicity of combination chemotherapy using paclitaxel, carboplatin and bleomycin in human lung and ovarian cancer
|
Author keywords
Bleomycin; Carboplatin; Combination chemotherapy; Isobologram; Paclitaxel
|
Indexed keywords
BLEOMYCIN;
BLEOMYCIN SULFATE;
CARBOPLATIN;
PACLITAXEL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
BODY WEIGHT;
CANCER CELL;
CELL CYCLE G2 PHASE;
COMBINATION CHEMOTHERAPY;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG POTENTIATION;
FLOW CYTOMETRY;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
MALE;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
ANIMALS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
BODY WEIGHT;
CARBOPLATIN;
CARCINOMA, NON-SMALL-CELL LUNG;
CYSTADENOCARCINOMA;
DRUG SYNERGISM;
FEMALE;
FLOW CYTOMETRY;
HUMANS;
LUNG NEOPLASMS;
MALE;
MICE;
MICE, SCID;
OVARIAN NEOPLASMS;
PACLITAXEL;
TUMOR CELLS, CULTURED;
|
EID: 0034881202
PISSN: 09594973
EISSN: None
Source Type: Journal
DOI: 10.1097/00001813-200108000-00006 Document Type: Article |
Times cited : (8)
|
References (30)
|